2.97
+0.37(+14.23%)
Currency In USD
Address
500 West 5th Street
Austin, TX 78703
United States of America
Phone
512 900 4690
Website
Sector
Healthcare
Industry
Biotechnology
Employees
44
First IPO Date
October 09, 2020
| Name | Title | Pay | Year Born |
| Dr. Taylor H. Schreiber M.D., Ph.D. | Co-Founder, Chief Executive Officer & Director | 742,560 | 1980 |
| Ms. Casi DeYoung | Chief Business Officer | 523,482 | 1971 |
| Dr. Abhinav A. Shukla Ph.D. | Chief Technical Officer | 567,398 | 1973 |
| Mr. Andrew R. Neill M.B.A. | Chief Financial Officer | 581,936 | 1986 |
| Dr. Arunthathy Nirmalini Pandite M.B.A., M.D. | Chief Medical Officer | 639,654 | 1959 |
| Ms. Kelli Collin M.S. | Senior Vice President of Quality | 0 | N/A |
| Dr. Thomas Lampkin Pharm.D. | Senior Vice President of Regulatory Affairs | 0 | N/A |
| Dr. Stephen Stout J.D., Ph.D. | General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer | 0 | 1975 |
| Mr. Suresh de Silva Ph.D. | Chief Scientific Officer | 0 | N/A |
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.